Salt Lake City, UT. , May 08, 2018 -- Utah Medical Products, Inc. (Nasdaq: UTMD) announces that its Board of Directors approved a quarterly cash dividend of twenty-seven cents ($.27) per share of common stock payable on July 6, 2018 to shareholders of record at the close of business on June 15, 2018. This is a 2% increase over the dividend declared in the same quarter of the prior year.
Utah Medical Products, Inc., with particular interest in health care for women and their babies, develops, manufactures and markets a broad range of disposable and reusable specialty medical devices recognized by clinicians in over a hundred countries around the world as the standard for obtaining optimal long term outcomes for their patients. For more information about Utah Medical Products, Inc., visit UTMD’s website at www.utahmed.com.
Contact: Utah Medical Products, Inc. Crystal Rios (801) 566-1200


Amazon Q2 Earnings Beat Estimates as AWS AI Growth Surges, But Q3 Revenue Forecast Disappoints
Arm Holdings Q1 Earnings Beat Estimates, Strong Q2 Outlook Fails to Lift ARM Stock
Sony Raises Full-Year Outlook After Q1 Profit Jumps 40% on Gaming and Chip Growth
Samsung Q2 Profit Surges on AI Memory Chip Demand, Forecasts Strong Second Half
Robinhood Q2 Earnings Beat Estimates, But HOOD Stock Falls as Investors Question Profit Quality
SK Hynix Q2 Profit Hits Record as AI Memory Chip Demand Fuels Growth
Russia Charges Telegram Founder Pavel Durov With Facilitating Terrorism, Seeks International Arrest
X Challenges Australia’s Expanded Social Media Ban Enforcement Powers
SpaceX Wins $1.6 Billion U.S. Space Force Launch Contracts for Falcon 9 Missions Through 2027
OpenAI Revenue Surges After GPT-5.6 Launch as IPO Expectations Grow
TSMC Gradually Restarts Japan Chip Plant After Kumamoto Earthquake
GSK Unveils $2.52 Billion Cost-Cutting Plan to Accelerate Drug Pipeline
Starbucks Stock Jumps as Q3 Earnings Beat, Sales Growth Drives Higher 2026 Outlook
Microsoft Stock Jumps as Azure Growth, AI Revenue Beat Expectations
Same sparkle, different story: how lab-grown diamonds are transforming the market
Tesla Weighs China Business Separation Amid SpaceX Merger Speculation
Meta CEO Zuckerberg Opposes U.S. Ban on Chinese AI Models, Warns Against Overregulation 



